MS Information Day 2026, Basel
The MS Informationstag 2026, held on February 14 at the University Hospital Basel, was a meaningful engagement between science and society.
For Clinnova Basel, the day represented a concrete opportunity to operationalize our mission: translating data-driven innovation into tangible value for people living with multiple sclerosis.
Throughout the event, the Clinnova team engaged with patients and families in both structured and spontaneous dialogue. At the booth, Dr. Bebeka Cosandey and Tanja Stoll held in-depth conversations about ongoing research initiatives and opportunities for study participation. The questions were precise, expectations clear, and the level of interest in contributing to research notably high.
The steady recruitment outcomes reflect more than successful outreach. They signal trust in science that is transparent, in research that is collaborative, and in innovation designed with patients, not only for patients.
Strategically, events such as the MS Informationstag are essential to Clinnova’s long-term vision. They strengthen our positioning at the intersection of clinical excellence, data innovation, and patient-centered research. They allow us to refine our communication, validate our approach, and ensure that scientific progress remains closely aligned with real-world needs.
Ultimately, this is how translational medicine achieves impact: not only through technological advancement, but through sustained dialogue, shared responsibility, and partnerships built on continuous engagement.
SPEAKERS:

Dr. Bebeka Cosandey & Tanja Stoll
